Table 3 Characteristics of Patients with or without SIRS on the 5th day

Age (years)

64 [54–68]

68 [61–77]

0.126

Day1/White blood cell (/mm³)

18,200 [17,200–24900]

13,600 [9900–16,000]

0.009

Day1/C-reactive protein (mg/L)

25.63 [9.58–31.38]

8.23 [4.1–16.6]

0.007

Day1/Presepsin (pg/mL)

1167 [878–5129]

419 [277–922]

0.006

Day1/Procalcitonin (ng/mL)

73.1 [25.06–103.73]

0.55 [0.14–2.06]

0.003

Day1/Aspartate transaminase (U/L)

34 [28–126]

24 [18–33]

0.013

Day1/Alanine transaminase (U/L)

23 [18–52]

16 [11–25]

0.056

Day1/γ-glutamyl transpeptidase (U/L)

48 [38–72]

28 [21–51]

0.133

Day1/Creatinine (mg/dL)

2.30 [1.72–2.71]

1.05 [0.85–1.84]

0.007

Day3/White blood cell (/mm³)

11,900 [9400–20,100]

8400 [5900–10,400]

0.021

Day3/C-reactive protein (mg/L)

25.58 [16.47–34.54]

10.71 [6.55–15.40]

 < 0.001

Day3/Presepsin (pg/mL)

633 [464–1360]

311 [196–695]

0.027

Day3/Procalcitonin (ng/mL)

20.34 [14.23–32.27]

1.35 [0.30–15.09]

0.005

Sex (male/female)

4/3

29/14

0.446

Urinary culture (P/N)

7/0

38/5

0.454

Blood culture (P/N)

6/1

18/25

0.039

Placement of urinary catheter (Y/N)

2/5

22/21

0.244

Urological cancer (Y/N)

1/6

14/29

0.311

Urinary calculi (Y/N)

4/3

8/35

0.048

DM (Y/N)

1/6

8/35

0.630

Surgical procedure (Y/N)

6/1

22/21

0.095

Internal use of steroid (Y/N)

2/5

7/36

0.370